Gene Expression Analysis Exposes Mitochondrial Abnormalities in a Mouse Model of Rett Syndrome

ABSTRACT Rett syndrome (RTT) is a severe neurological disorder caused by mutations in the X-linked MECP2 gene, which encodes a methyl-CpG binding transcriptional repressor. Using the Mecp2-null mouse (an animal model for RTT) and differential display, we found that mice with neurological symptoms overexpress the nuclear gene for ubiquinol-cytochrome c reductase core protein 1 (Uqcrc1). Chromatin immunoprecipitation demonstrated that MeCP2 interacts with the Uqcrc1 promoter. Uqcrc1 encodes a subunit of mitochondrial respiratory complex III, and isolated mitochondria from the Mecp2-null brain showed elevated respiration rates associated with respiratory complex III and an overall reduction in coupling. A causal link between Uqcrc1 gene overexpression and enhanced complex III activity was established in neuroblastoma cells. Our findings raise the possibility that mitochondrial dysfunction contributes to pathology of the Mecp2-null mouse and may contribute to the long-known resemblance between Rett syndrome and certain mitochondrial disorders.

[1]  A. Bird,et al.  Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. , 2005, Human molecular genetics.

[2]  Rodney C Samaco,et al.  Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. , 2005, Human molecular genetics.

[3]  Jan-Fang Cheng,et al.  Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome , 2005, Nature Genetics.

[4]  M. Johnston,et al.  Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain , 2004, Neuroscience.

[5]  Noriyuki Kishi,et al.  MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions , 2004, Molecular and Cellular Neuroscience.

[6]  A. Bird,et al.  The major form of MeCP2 has a novel N-terminus generated by alternative splicing. , 2004, Nucleic acids research.

[7]  Eric C. Griffith,et al.  Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 , 2003, Science.

[8]  Daisuke Hattori,et al.  DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.

[9]  A. Bird,et al.  DNA methylation and Rett syndrome. , 2003, Human molecular genetics.

[10]  J. Eubanks,et al.  The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. , 2003, Journal of neurobiology.

[11]  R. Jaenisch,et al.  Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[13]  Brendan H. Lee,et al.  Infantile hypotonia as a presentation of Rett syndrome. , 2002, American journal of medical genetics.

[14]  Juan I. Young,et al.  Mice with Truncated MeCP2 Recapitulate Many Rett Syndrome Features and Display Hyperacetylation of Histone H3 , 2002, Neuron.

[15]  D. Armstrong.  Neuropathology of Rett syndrome. , 2002, Mental retardation and developmental disabilities research reviews.

[16]  D. Busija,et al.  Isolation and characterization of intact mitochondria from neonatal rat brain. , 2001, Brain research. Brain research protocols.

[17]  F. Fleury-Olela,et al.  Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs. , 2001, Nucleic acids research.

[18]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[19]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.

[20]  N. Sims,et al.  Improved recovery of highly enriched mitochondrial fractions from small brain tissue samples. , 2000, Brain research. Brain research protocols.

[21]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[22]  T. A. Link,et al.  Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. , 1998, Science.

[23]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[24]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[25]  L. Vergani,et al.  Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels , 1997, Electrophoresis.

[26]  A. Bird,et al.  DNA methylation specifies chromosomal localization of MeCP2 , 1996, Molecular and cellular biology.

[27]  G. Hofhaus,et al.  Use of polarography to detect respiration defects in cell cultures. , 1996, Methods in enzymology.

[28]  H. Schägger.  Quantification of oxidative phosphorylation enzymes after blue native electrophoresis and two‐dimensional resolution: Normal complex I protein amounts in Parkinson's disease conflict with reduced catalytic activities , 1995, Electrophoresis.

[29]  R. Riikonen,et al.  Elevated CSF lactate in the Rett syndrome: cause or consequence? , 1994, Brain and Development.

[30]  A. Federico,et al.  Mitochondrial dysfunction in Rett syndrome An ultrastructural and biochemical study , 1993, Brain and Development.

[31]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[32]  T. Matsuishi,et al.  The rett syndrome and CSF lactic acid patterns , 1992, Brain and Development.

[33]  S. Coker,et al.  Rett Syndrome and Mitochondrial Enzyme Deficiencies , 1991, Journal of child neurology.

[34]  T. Kurczynski,et al.  Mitochondrial alterations in Rett syndrome. , 1989, Pediatric neurology.

[35]  J. Opitz,et al.  Rett syndrome: genetic clues based on mitochondrial changes in muscle. , 1989, American journal of medical genetics.

[36]  G. Peterson,et al.  A simplification of the protein assay method of Lowry et al. which is more generally applicable. , 1977, Analytical biochemistry.

[37]  J. Clark,et al.  SYNAPTIC AND NON‐SYNAPTIC MITOCHONDRIA FROM RAT BRAIN: ISOLATION AND CHARACTERIZATION , 1977, Journal of neurochemistry.